AMD stock price has bounced back in the past few months, mirroring the performance of most companies, which have soared after ...

The company's MI300 accelerator has been a standout performer, with AMD raising its 2024 revenue forecast for this ... market poses both opportunities and challenges for AMD.

Shares of Advanced Micro Devices (NASDAQ:AMD) gained 10.50% over the past month, bringing the stock’s year-to-date gain to 5.11%. However, over the past year, the chipmaker remains down 21.63%. For ...

AMD's AI chip revenue fails to impress investors, shares fall 5% Nvidia's dominance in AI chips challenges AMD's market position AMD forecasts Q1 revenue above analyst estimates, driven by PC ...

AMD's new AI products ... According to consensus, the revenue CAGR for years 1-5 is around 18%. This is an aggressive assumption, but using an optimistic forecast as the first scenario looks ...

AMD's Q4 revenue beat estimates, but analysts lowered price forecasts due to concerns over ... in aerospace/defense and test/emulation, but challenges in cyclical sectors like industrial and ...

Given two endpoints and a compound annual growth rate between those two points over a specific amount of time is not as ...

Down almost 45% from all-time highs, AMD is an AI stock that is positioned to deliver outsized gains to shareholders.

As a result, Intel is forecasting revenue of $11.2 billion to $12.4 for its second quarter, a “wider-than-normal” range that would represent a decrease of 2 to 12 percent sequentially in ...

However, as the company looks forward, AMD is expecting some significant economic challenges. Specifically, the company is expecting a $700 million revenue hit for the current quarter and a $1.5 ...

Advanced Micro Devices Inc. Chief Executive Officer Lisa Su said her company’s latest AI processors can challenge Nvidia Corp ...

Advanced Micro Devices (NASDAQ: AMD) recently introduced its latest artificial intelligence (AI) chip as it looks to make a dent in Nvidia's (NASDAQ: NVDA) huge market share. While AMD, as it is ...